30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Idenix Pharmaceuticals LLC (IDIX)

Track

Stock chart
Ticker: IDIX Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BAUPOST GROUP LLC/MA
1 purchase — total 106,731,567 USD
Buy 31 Jan 2014
Value US$4,485,966.99 | Price 315.16 | Shares 6,617
Sale 16 Mar 2012
Value US$3,604,616.03 | Price 316.14 | Shares 27,950
Buy 23 Feb 2012
Value US$15,762.87 | Price 7.39 | Shares 2,133
Buy 23 Feb 2012
Value US$3,214.36 | Price 6.52 | Shares 493
Buy 23 Feb 2012
Value US$2,528.80 | Price 5.80 | Shares 436
Buy 23 Feb 2012
Value US$5,112.57 | Price 5.79 | Shares 883
Buy 23 Feb 2012
Value US$40,414.92 | Price 5.46 | Shares 7,402
Buy 23 Feb 2012
Value US$58,422.63 | Price 5.11 | Shares 11,433
Buy 23 Feb 2012
Value US$198.90 | Price 5.10 | Shares 39
Buy 23 Feb 2012
Value US$11,722.47 | Price 3.79 | Shares 3,093
Buy 23 Feb 2012
Value US$13,745.12 | Price 3.17 | Shares 4,336
Buy 23 Feb 2012
Value US$705.28 | Price 3.04 | Shares 232
Buy 23 Feb 2012
Value US$1,268.19 | Price 2.97 | Shares 427
Buy 23 Feb 2012
Value US$26,521.60 | Price 2.96 | Shares 8,960
Buy 23 Feb 2012
Value US$9,039.30 | Price 2.90 | Shares 3,117
Buy 23 Feb 2012
Value US$3,764.85 | Price 2.85 | Shares 1,321
Buy 23 Feb 2012
Value US$2,771.66 | Price 2.78 | Shares 997
Buy 23 Feb 2012
Value US$2,681.93 | Price 2.69 | Shares 997
Buy 23 Feb 2012
Value US$6,382.08 | Price 2.56 | Shares 2,493
Buy 23 Feb 2012
Value US$904.02 | Price 2.47 | Shares 366
Buy 23 Feb 2012
Value US$86,121.35 | Price 2.41 | Shares 35,735
Buy 22 Nov 2011
Value US$50,215.62 | Price 5.46 | Shares 9,197
Buy 22 Nov 2011
Value US$10,766.77 | Price 5.11 | Shares 2,107
Buy 22 Nov 2011
Value US$95,071.60 | Price 4.70 | Shares 20,228
Buy 22 Nov 2011
Value US$530.60 | Price 3.79 | Shares 140
Buy 22 Nov 2011
Value US$3,632.82 | Price 3.17 | Shares 1,146
Buy 22 Nov 2011
Value US$19,104.20 | Price 2.95 | Shares 6,476
Buy 22 Nov 2011
Value US$27,078.76 | Price 2.41 | Shares 11,236
Buy 13 Apr 2011
Value US$4,999,999.20 | Price 2.80 | Shares 1,785,714
Buy 25 Feb 2011
Value US$1,052.66 | Price 5.11 | Shares 206
Buy 25 Feb 2011
Value US$6,828.80 | Price 3.88 | Shares 1,760
Buy 25 Feb 2011
Value US$3,259.40 | Price 3.79 | Shares 860
Buy 25 Feb 2011
Value US$2,655.12 | Price 2.96 | Shares 897
Buy 25 Feb 2011
Value US$41,620.70 | Price 2.41 | Shares 17,270
Buy 26 Nov 2010
Value US$2,653.56 | Price 5.46 | Shares 486
Buy 26 Nov 2010
Value US$6,806.52 | Price 5.11 | Shares 1,332
Buy 26 Nov 2010
Value US$625.35 | Price 3.79 | Shares 165
Buy 26 Nov 2010
Value US$130.24 | Price 2.96 | Shares 44
Buy 26 Nov 2010
Value US$2,170.08 | Price 2.64 | Shares 822
Buy 26 Nov 2010
Value US$34,303.94 | Price 2.41 | Shares 14,234
Buy 23 Aug 2010
Value US$3,081.27 | Price 3.79 | Shares 813
Buy 23 Aug 2010
Value US$276.64 | Price 3.04 | Shares 91
Buy 23 Aug 2010
Value US$775.52 | Price 2.96 | Shares 262
Buy 23 Aug 2010
Value US$86,875.68 | Price 2.41 | Shares 36,048
Buy 8 Jun 2010
Value US$3,255.91 | Price 2.41 | Shares 1,351
Buy 26 Feb 2010
Value US$4,511.52 | Price 2.41 | Shares 1,872
Buy 16 Dec 2009
Value US$22,020.44 | Price 2.12 | Shares 10,387
Buy 15 Dec 2009
Value US$32,250.00 | Price 2.15 | Shares 15,000
Buy 14 Dec 2009
Value US$23,320.00 | Price 2.12 | Shares 11,000
Buy 11 Dec 2009
Value US$17,915.04 | Price 2.08 | Shares 8,613
Buy 10 Dec 2009
Value US$10,250.00 | Price 2.05 | Shares 5,000
Buy 24 Nov 2009
Value US$37,800.00 | Price 1.89 | Shares 20,000
Buy 21 Aug 2009
Value US$8,268.71 | Price 2.41 | Shares 3,431
Buy 29 May 2009
Value US$6,421.62 | Price 2.62 | Shares 2,451
Buy 23 Feb 2009
Value US$13,120.04 | Price 2.41 | Shares 5,444
Buy 19 Nov 2008
Value US$19,225.35 | Price 4.05 | Shares 4,747
Buy 2 Sep 2008
Value US$13,636.22 | Price 2.93 | Shares 4,654
Buy 29 May 2008
Value US$2,226.84 | Price 2.41 | Shares 924
Buy 11 Mar 2008
Value US$133,500.00 | Price 4.45 | Shares 30,000
Buy 13 Jul 2007
Value US$1,536.00 | Price 3.84 | Shares 400
Buy 6 Jun 2006
Value US$7,475.20 | Price 20.48 | Shares 365
Buy 9 May 2006
Value US$91,300.00 | Price 9.13 | Shares 10,000
Buy 8 May 2006
Value US$1,852.00 | Price 9.26 | Shares 200
Buy 4 Apr 2006
Value US$47,683.74 | Price 16.23 | Shares 2,938
Sale 14 Nov 2005
Value US$12,973,953.78 | Price 20.61 | Shares 629,498
Buy 31 Oct 2005
Value US$81,185,489.91 | Price 20.61 | Shares 3,939,131
Buy 27 Jul 2004
Value US$100,800.00 | Price 14.00 | Shares 7,200
Buy 27 Jul 2004
Value US$100,800.00 | Price 14.00 | Shares 7,200
Buy 27 Jul 2004
Value US$89,096.00 | Price 14.00 | Shares 6,364
Buy 27 Jul 2004
Value US$140,000.00 | Price 14.00 | Shares 10,000
Buy 27 Jul 2004
Value US$112,000.00 | Price 14.00 | Shares 8,000
Buy 27 Jul 2004
Value US$280,000.00 | Price 14.00 | Shares 20,000
Buy 27 Jul 2004
Value US$100,800.00 | Price 14.00 | Shares 7,200
Buy 27 Jul 2004
Value US$187,600.00 | Price 14.00 | Shares 13,400
Sale 27 Jul 2004
Value US$7,117,194.00 | Price 14.00 | Shares 508,371
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-02-04 2014-01-31 B Purchase BAUPOST GROUP LLC/MA Large shareholder
6,617 -6.9%
315.16
US$4,485,967 		6,617 -6.9% 315.16 US$4,485,967
2012-03-20 2012-03-16 S Sale Fanning Paul

SVP, Human Resources

Officer
27,950 +40.0%
316.14
US$3,604,616 		27,950 +40.0% 316.14 US$3,604,616
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
95,903 +21.7%
104.09
US$1,386,527 		95,903 +21.7% 104.09 US$1,386,527
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
493 +0.0%
6.52
US$3,214 		493 +0.0% 6.52 US$3,214
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
436 +0.0%
5.80
US$2,529 		436 +0.0% 5.80 US$2,529
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
883 +0.0%
5.79
US$5,113 		883 +0.0% 5.79 US$5,113
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
7,402 +0.0%
5.46
US$40,415 		7,402 +0.0% 5.46 US$40,415
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
11,433 +0.0%
5.11
US$58,423 		11,433 +0.0% 5.11 US$58,423
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
39 +0.0%
5.10
US$199 		39 +0.0% 5.10 US$199
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
3,093 +0.0%
3.79
US$11,722 		3,093 +0.0% 3.79 US$11,722
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
4,336 +0.0%
3.17
US$13,745 		4,336 +0.0% 3.17 US$13,745
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
232 +0.0%
3.04
US$705 		232 +0.0% 3.04 US$705
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
427 +0.0%
2.97
US$1,268 		427 +0.0% 2.97 US$1,268
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
8,960 +0.0%
2.96
US$26,522 		8,960 +0.0% 2.96 US$26,522
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
3,117 +0.0%
2.90
US$9,039 		3,117 +0.0% 2.90 US$9,039
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
1,321 +0.0%
2.85
US$3,765 		1,321 +0.0% 2.85 US$3,765
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2.78
US$2,772 		997 +0.0% 2.78 US$2,772
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2.69
US$2,682 		997 +0.0% 2.69 US$2,682
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
2,493 +0.0%
2.56
US$6,382 		2,493 +0.0% 2.56 US$6,382
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
366 +0.0%
2.47
US$904 		366 +0.0% 2.47 US$904
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
35,735 +0.1%
2.41
US$86,121 		35,735 +0.1% 2.41 US$86,121
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
9,197 +0.0%
5.46
US$50,216 		9,197 +0.0% 5.46 US$50,216
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
2,107 +0.0%
5.11
US$10,767 		2,107 +0.0% 5.11 US$10,767
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
20,228 +0.1%
4.70
US$95,072 		20,228 +0.1% 4.70 US$95,072
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
140 +0.0%
3.79
US$531 		140 +0.0% 3.79 US$531
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
1,146 +0.0%
3.17
US$3,633 		1,146 +0.0% 3.17 US$3,633
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
6,476 +0.0%
2.95
US$19,104 		6,476 +0.0% 2.95 US$19,104
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
11,236 +0.0%
2.41
US$27,079 		11,236 +0.0% 2.41 US$27,079
2011-04-13 2011-04-13 B Purchase NOVARTIS AG

Indirect 10% Owner
1,785,714 +5.7%
2.80
US$4,999,999 		1,785,714 +5.7% 2.80 US$4,999,999
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
206 +0.0%
5.11
US$1,053 		206 +0.0% 5.11 US$1,053
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
1,760 +0.0%
3.88
US$6,829 		1,760 +0.0% 3.88 US$6,829
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
860 +0.0%
3.79
US$3,259 		860 +0.0% 3.79 US$3,259
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
897 +0.0%
2.96
US$2,655 		897 +0.0% 2.96 US$2,655
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
17,270 +0.1%
2.41
US$41,621 		17,270 +0.1% 2.41 US$41,621
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
486 +0.0%
5.46
US$2,654 		486 +0.0% 5.46 US$2,654
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
1,332 +0.0%
5.11
US$6,807 		1,332 +0.0% 5.11 US$6,807
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
165 +0.0%
3.79
US$625 		165 +0.0% 3.79 US$625
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
44 +0.0%
2.96
US$130 		44 +0.0% 2.96 US$130
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
822 +0.0%
2.64
US$2,170 		822 +0.0% 2.64 US$2,170
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
14,234 +0.0%
2.41
US$34,304 		14,234 +0.0% 2.41 US$34,304
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
813 +0.0%
3.79
US$3,081 		813 +0.0% 3.79 US$3,081
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
91 +0.0%
3.04
US$277 		91 +0.0% 3.04 US$277
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
262 +0.0%
2.96
US$776 		262 +0.0% 2.96 US$776
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
36,048 +0.1%
2.41
US$86,876 		36,048 +0.1% 2.41 US$86,876
2010-06-08 2010-06-08 B Purchase NOVARTIS AG

Indirect 10% Owner
1,351 +0.0%
2.41
US$3,256 		1,351 +0.0% 2.41 US$3,256
2010-02-26 2010-02-26 B Purchase NOVARTIS AG

Indirect 10% Owner
1,872 +0.0%
2.41
US$4,512 		1,872 +0.0% 2.41 US$4,512
2009-12-17 2009-12-16 B Purchase HODGSON THOMAS R Non-Executive Director
10,387 +22.2%
2.12
US$22,020 		10,387 +22.2% 2.12 US$22,020
2009-12-17 2009-12-15 B Purchase HODGSON THOMAS R Non-Executive Director
15,000 +47.2%
2.15
US$32,250 		15,000 +47.2% 2.15 US$32,250
2009-12-14 2009-12-14 B Purchase HODGSON THOMAS R Non-Executive Director
11,000 +52.9%
2.12
US$23,320 		11,000 +52.9% 2.12 US$23,320
2009-12-14 2009-12-11 B Purchase HODGSON THOMAS R Non-Executive Director
8,613 +70.6%
2.08
US$17,915 		8,613 +70.6% 2.08 US$17,915
2009-12-14 2009-12-10 B Purchase HODGSON THOMAS R Non-Executive Director
5,000 +69.4%
2.05
US$10,250 		5,000 +69.4% 2.05 US$10,250
2009-11-24 2009-11-24 B Purchase Weidenbruch John

Ex. VP, Gen. Counsel and Secr.

Officer
20,000 +133.3%
1.89
US$37,800 		20,000 +133.3% 1.89 US$37,800
2009-08-24 2009-08-21 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
3,431 +0.0%
2.41
US$8,269 		3,431 +0.0% 2.41 US$8,269
2009-05-29 2009-05-29 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
2,451 +0.0%
2.62
US$6,422 		2,451 +0.0% 2.62 US$6,422
2009-02-23 2009-02-23 B Purchase NOVARTIS AG

Indirect 10% owner
5,444 +0.0%
2.41
US$13,120 		5,444 +0.0% 2.41 US$13,120
2008-11-25 2008-11-19 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
4,747 +0.0%
4.05
US$19,225 		4,747 +0.0% 4.05 US$19,225
2008-09-03 2008-09-02 B Purchase NOVARTIS AG Large shareholder
4,654 +0.0%
2.93
US$13,636 		4,654 +0.0% 2.93 US$13,636
2008-05-30 2008-05-29 B Purchase NOVARTIS AG Large shareholder
924 +0.0%
2.41
US$2,227 		924 +0.0% 2.41 US$2,227
2008-03-13 2008-03-11 B Purchase Mayers Douglas L

EVP and Chief Medical Officer

Officer
30,000 +inf%
4.45
US$133,500 		30,000 +inf% 4.45 US$133,500
2007-07-19 2007-07-13 B Purchase Koppy Susan

Sr. VP, Business and Corp Dev.

Officer
400 +160.0%
3.84
US$1,536 		400 +160.0% 3.84 US$1,536
2006-06-08 2006-06-06 B Purchase NOVARTIS AG Large shareholder
365 +0.0%
20.48
US$7,475 		365 +0.0% 20.48 US$7,475
2006-05-11 2006-05-09 B Purchase Sommadossi Jean-Pierre

President, CEO, Chairman

Executive Director
10,000 +0.5%
9.13
US$91,300 		10,000 +0.5% 9.13 US$91,300
2006-05-10 2006-05-08 B Purchase Koppy Susan

Sr. VP, Business and Corp Dev.

Officer
200 +400.0%
9.26
US$1,852 		200 +400.0% 9.26 US$1,852
2006-04-06 2006-04-04 B Purchase NOVARTIS AG Large shareholder
2,938 +0.0%
16.23
US$47,684 		2,938 +0.0% 16.23 US$47,684
2005-11-16 2005-11-14 S Sale Pollard-Knight Denise Non-Executive Director
629,498 -67.6%
20.61
US$12,973,954 		629,498 -67.6% 20.61 US$12,973,954
2005-11-02 2005-10-31 B Purchase NOVARTIS AG Large shareholder
3,939,131 +14.4%
20.61
US$81,185,490 		3,939,131 +14.4% 20.61 US$81,185,490
2004-07-29 2004-07-27 B Purchase
HODGSON THOMAS R
7,200 +20.5%
14.00
US$100,800 		7,200 +20.5% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
Corcoran Andrea

Exec. VP, Legal and Admin.
7,200 +12.8%
14.00
US$100,800 		7,200 +12.8% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
3.7
Sommadossi Jean-Pierre

President, CEO, Chairman

Executive Director
6,364 +0.3%
14.00
US$89,096 		6,364 +0.3% 14.00 US$89,096
2004-07-29 2004-07-27 B Purchase
3.2
Macdonald Guy

Executive VP, Operations
10,000 +inf%
14.00
US$140,000 		10,000 +inf% 14.00 US$140,000
2004-07-29 2004-07-27 B Purchase
1.4
Arkowitz David

Chief Financial Officer
8,000 +inf%
14.00
US$112,000 		8,000 +inf% 14.00 US$112,000
2004-07-29 2004-07-27 B Purchase
3.0
BARSHEFSKY CHARLENE
20,000 +inf%
14.00
US$280,000 		20,000 +inf% 14.00 US$280,000
2004-07-29 2004-07-27 B Purchase
CRAMB CHARLES W JR
7,200 +inf%
14.00
US$100,800 		7,200 +inf% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
Egan James

Sr. VP, Business and Corp Dev
13,400 +6.2%
14.00
US$187,600 		13,400 +6.2% 14.00 US$187,600
2004-07-28 2004-07-27 S Sale
3.1
GADICKE ANSBERT
Large shareholder
508,371 -9.6%
14.00
US$7,117,194 		508,371 -9.6% 14.00 US$7,117,194
Explore more

More insider trading research around Idenix Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America